SCHEMBL153413

SCHEMBL153413

Brc1cnc2[nH]ccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 7/20 0.55
AXL P30530 3/20 0.55
PIK3CD O00329 1/20 0.53
PIK3CA P42336 1/20 0.53
PIK3CB P42338 1/20 0.53
PIK3CG P48736 1/20 0.53
RIPK1 Q13546 4/20 0.51
MAPK1 P28482 2/20 0.50
NUDT1 P36639 2/20 0.47
CYP2A6 P11509 1/20 0.45
AHR P35869 1/20 0.45
NR4A2 P43354 1/20 0.45
KDR P35968 3/20 0.45
FGFR1 P11362 2/20 0.45
PLK4 O00444 2/20 0.45
ROCK2 O75116 2/20 0.45
PRKD3 O94806 2/20 0.45
MAP4K4 O95819 2/20 0.45
INSR P06213 2/20 0.45
CDK1 P06493 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Magnesium SCHEMBL30992114 0.98 CDK8 (0.53) CDK8AXLPIK3CDPIK3CAPIK3CB
Quinoline SCHEMBL27994190 0.83 AXL (0.51) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL4831501 0.78 CDK8 (0.81) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL878796 0.77 ULK1 (0.48) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL23655689 0.77 CDK8 (0.56) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL3348675 0.75 CDK8 (0.55) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL294106 0.75 CDK8 (0.55) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL297772 0.75 CDK8 (0.55) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL294108 0.75 CDK8 (0.55) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL11968477 0.75 CDK8 (0.55) CDK8AXLPIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2526 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4682148-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES AbbVie Ireland Unlimited Company (IE) 2026-01-21 EP claimed
EP-4474383-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES AbbVie Ireland Unlimited Company (IE) 2024-12-11 EP claimed
CN-118373820-A Continuous preparation method and continuous synthesis device of 5-hydroxy-7-azaindole 峰成医药科技(天津)有限公司 2024-07-23 CN claimed
CN-115057856-B 3, 5-disubstituted-7-azaindole derivative and synthetic method and application thereof 澳门科技大学 2024-04-02 CN claimed
CN-115141197-B 3-aromatic heterocycle substituted phenyl derivative and preparation method and application thereof 安徽医科大学 2024-03-26 CN claimed
CN-117126157-A Preparation method of 5-hydroxy-7-azaindole 舞阳威森生物医药有限公司 2023-11-28 CN claimed
CN-115991705-A 3- (1H pyrrolo [2,3-b ] pyridin-5-yl) benzoyl derivatives, preparation and application thereof 安徽医科大学 2023-04-21 CN claimed
US-20220315555-A1 APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE INC. (US) 2022-10-06 US claimed
CN-115141197-A 3-aromatic heterocyclic substituted phenyl derivative and preparation method and application thereof 安徽医科大学 2022-10-04 CN claimed
CN-115057856-A 3, 5-disubstituted-7 azaindole derivative and synthesis method and application thereof 澳门科技大学 2022-09-16 CN claimed
CN-101781298-A Method for preparing 5-cyano-7-azaindole ABA CHEMICALS SUZHOU LTD 2010-07-21 CN claimed
CN-101607958-A Quinazoline compound ASTRAZENECA AB (SE) 2009-12-23 CN claimed
US-20090215771-A1 JNK INHIBITORS GRACZYK PIOTR 2009-08-27 US claimed
US-20090156821-A1 Quinazoline compounds ASTRAZENECA AB 2009-06-18 US claimed
US-7268230-B2 Quinazoline compounds ASTRAZENECA AB (SE) 2007-09-11 US claimed
US-20060270646-A1 Jnk inhibitors EISAI CO., LTD. (JP) 2006-11-30 US claimed
CN-1625555-A Quinazoline compounds ASTRAZENECA AB (SE) 2005-06-08 CN claimed
US-20050085465-A1 Angiogenesis inhibitor; antiarthritic agents; psoriasis; anticancer agents ASTRAZENECA AB (SE) 2005-04-21 US claimed
EP-1474420-A1 QUINAZOLINE COMPOUNDS Astrazeneca AB (SE) 2004-11-10 EP claimed
WO-2003064413-A1 QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2003-08-07 WO claimed